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more software based verification (48%) and to stopping 
measurements altogether (25%). 
Conclusions: There has been a significant increase in the 
uptake of IMRT techniques within UK centres in recent years, 
possibly aided by the RIF. VMAT delivery has taken over a 
significant proportion of step-and-shoot IMRT and also some 
dynamic fixed gantry IMRT. Whilst the verification workload 
burden is still considerable for physics staff, there has been a 
shift towards software based verification to replace physical 
measurements.  
 
PO-0855   
Dose evaluation by patient in-vivo dosimetryin total body 
irradiation  
N. Hussain1, A. Naga2, Y. Bahadur3, A. Al-Hebshi4, C. 
Constantinescu1 
1King Faisal Specialist Hospital and Research Center, 
Biomedical Physics, Jeddah, Saudi Arabia  
2National Cancer Institute Cairo University, Radiotherapy, 
Cairo, Egypt  
3King Abdulaziz University Hospital, Radiology, Jeddah, Saudi 
Arabia  
4King Faisal Specialist Hospital and Research Center, 
Oncology, Jeddah, Saudi Arabia  
 
Purpose/Objective: Total body irradiation (TBI) is a special 
radiotherapy technique, used before bone marrow 
transplant, aiming to deliver a homogeneous dose to the 
whole body, with an accepted range of dose homogeneity 
within ±10% of the prescribed dose. The moving couch 
technique provides dose uniformity due to the application of 
dynamic TPR. 
The purpose of this study is to assess the reliability of metal–
oxide–semiconductor field-effect transistors(MOSFETs) for in-
vivo verification of the delivered dose and to evaluate the 
patient dose homogeneity for our TBI moving couch 
technique. 
Materials and Methods: Dosimetric data of 16 patients 
treated by TBI with moving couch and 6 MV were 
retrospectively analyzed. 
MOSFET dosimeters were calibrated against a Farmer 
chamber in a Perspex slab phantom and tested in an 
anthropomorphic phantom, under moving couch TBI 
conditions. 
Before treatment, a total body CT scan was acquired with 
the patient in treatment position. CT images were used to 
calculate the mid-line dose at 5 locations in the patient’s 
body (head, neck, mediastinum, umbilicus and thigh), using 
Tissue-Phantom-Ratio (TPR) values according to the 
separation of each location and prescribed dose at mid-line 
of the umbilicus. 
Patient in-vivo dosimetry was performed during first fraction 
for all patients. Patient entrance dose was measured by 
MOSFETs at the same 5 locations, then converted to mid-line 
dose, and compared to calculated values. 
Patient dose homogeneity was assessed by the percent 
difference between mid-line values of doses and mid-line 
dose at the umbilicus, for measured and calculated values.  
Results: The mean percentage dose difference between 
measured and calculated values were: -2% ± 6.1% for head, 
0.2% ± 9.5% for neck, 2.3% ± 8.8% for mediastinum, 1% ± 7% 
for umbilicus, and -2.9% ± 9.3% for thigh. A difference in dose 
of more than 10% was found in 14/16 (87.5%) measurements. 
Fig. 1. Comparison between in-vivo measured dose and 
calculated dose at head, neck, mediastinum, umbilicus and 
thigh. Linear regression curves and correlation coefficients 
are specified. The reference curve shows equal measured and 
calculated doses. 
 
 
Fig. 2.Histogram of the difference between in-vivo measured 
and calculated doses at head, neck, mediastinum, umbilicus 
and thigh. The interval of ± 5% is specified. 
 
Acceptable patient dose homogeneity within ±10% of the 
prescribed dose, as determined by in-vivo measurements, 
was achieved for 11/16 (68.7%) patients at head, 13/16 
(81.2%) patients at neck, 13/16 (81.2%) patients at 
mediastinum, and 13/16 (81.2%) patients at thigh location. 
For 11/16 (68.7%) patients hose homogeneity was acceptable 
over the whole body. 
Table 1. Comparison of patient dose homogeneity (defined by 
the percent difference between midline values of doses and 
midline dose at the umbilicus) between in-vivo measurement 
and calculation.  
 
 
Conclusions: If properly calibrated, MOSFETs are suitable for 
TBI in-vivo dosimetry. 
Moving couch technique for TBI enables acceptable patient 
dose homogeneity. Dose homogeneity can be improved by 
adding tissue compensators for head, neck and legs or by 
speed modulation. 
 
 
 
 
 
